This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on January 17, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

FY25 Vaccines for Children

Closed

75D30125R00065Federal

Submission Closed01/30/2025, 06:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

SLED

Pharmacy and Lab Equipment SupplyThis subcontract, managed by the Bristol Alliance of Companies through the Bristol - Temecula office, involves the supply and installation of specialized pharmacy and lab equipment for prime contractors working on VA Health Care System projects. The scope of work specifically includes the provision of industrial steel shelving and fume hoods that comply with Division 11 53 0 standards. The contractor is responsible for ensuring that all pharmacy equipment is delivered, positioned, and fully installed. The project is located in Loma Linda, California, and falls under NAICS code 325412. Interested parties should note that the solicitation was posted on October 22, 2026, with a response deadline of October 23, 2026.

Bristol Alliance of Companies

POSTED

DEADLINE

Bacitracin Zinc and Polymyxin B Sulfate Ointment ProductionThis subcontract involves the manufacture and supply of USP-grade Bacitracin Zinc and Polymyxin B Sulfate Ointment for prime contractors supporting Department of Defense DLA Troop Support Medical Supply Chain projects. The scope of work includes compounding the ointment to USP standards, filling and sealing 1/32 oz unit dose foil packets, and organizing them into packages of 144 units. Strict adherence to quality and storage protocols is required, including maintaining a temperature-controlled environment between 20C and 25C and ensuring compliance with DLA RP001 and Medical Marking Standard No. 1. The contract falls under NAICS code 325412 and requires the delivery of finished pharmaceutical packages to the designated place of performance.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Berry Flavored Electrolyte Oral Rehydration Powder SupplyThis subcontract involves the supply of berry-flavored electrolyte oral rehydration powder for prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain Pharm FSA. The required OTC powder must be manufactured using pharmaceutical-grade mixing equipment and adhere to a specific formulation per 21g packet consisting of 665mg Sodium, 390mg Potassium, 80mg Citrate, 83mg Magnesium, and 3mg Zinc. The contractor must ensure full compliance with FDA OTC standards, the Buy American Act, and the Berry Amendment. The scope of delivery includes two packages, each containing 100 packets, with performance taking place at FPO 96679. This opportunity falls under NAICS code 325412 and was posted on October 21, 2026, with a response deadline of October 27, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Mechanical Food Refrigerator (NSN 4110-01-505-3438)This subcontract involves the supply of one mechanical food refrigerator meeting NSN 4110-01-505-3438 specifications for prime contractors supporting DLA supply contracts at the Pearl Harbor Naval Shipyard IMF in Hawaii. The unit must utilize approved R134A or R404A refrigerants and be delivered in fully functional condition. The contractor is required to adhere to ASTM D3951 and MIL-STD-129 standards for packing and marking. Additionally, the procurement must comply with the Buy American and Balance of Payments Program. This requirement is managed by the Department of Defense under the Subsistence FSE Supply Chain.

SUBSISTENCE FSE SUPPLY CHAIN

POSTED

DEADLINE

Supply of Mechanical Food Refrigerator (NSN 4110-01-505-3687)This subcontract involves the supply of one mechanical food refrigerator matching NSN 4110-01-505-3687 for prime contractors supporting DLA Troop Support Subsistence equipment. The equipment must utilize approved R134A or R404A refrigerants and strictly adhere to ASTM D3951, MIL-STD-129, and RP001 DLA packaging and marking standards. The Department of Defense, specifically the Subsistence FSE Supply Chain, requires the delivery of the fully compliant unit to the Pearl Harbor Naval Shipyard IMF in Hawaii. The procurement falls under NAICS code 325412, with a response deadline set for October 23, 2026.

SUBSISTENCE FSE SUPPLY CHAIN

POSTED

DEADLINE

Supply of Tolnaftate Powder, USP 1%

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BACITRACIN ZINC AND PO

Solicitation # SPE2DP-27-T-0140

Solicitation SPE2DP-27-T-0140 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Bacitracin Zinc and Polymyxin B Sulfate Ointment, USP. The requirement is for one package containing 144 unit dose foil packets, each sized at 1/32 oz (.94gm). The product must be stored between 20°C and 25°C and has a non-extendable shelf life of 36 months. Delivery is required within 20 days of award, with a required delivery date of October 23, 2026, shipped FOB Destination to the USS Tucson (SSN 770). The contractor must adhere to strict packaging and marking standards, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial and sealed to protect contents from damage, with palletization following DLA requirement RP001. If the material is deemed hazardous, it must comply with FED-STD-313 and 29 CFR 1910.1200 for Safety Data Sheets and labeling; otherwise, ASTM D3951 applies. The contract incorporates several federal regulations, including FAR 52.246-2 for destination inspection and acceptance, DFARS 252.204-7012 for safeguarding covered defense information, and the Buy American Act. All quotes must be submitted via the DIBBS portal.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0138

Solicitation SPE2DP-27-T-0138 is a fixed-price procurement for Tolnaftate Powder, USP 1%, 45 GM, identified by NSN 6505014807897. The requirement consists of two line items totaling 13 bottles, with a delivery window of 20 days after order and an original required delivery date of October 23, 2026. The supplies are to be delivered FOB Destination to the USS TUCSON SSN 770 at FPO AP 96679. This procurement is managed by the DLA Troop Support Medical Supply Chain Pharm FSA under NAICS code 325412. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial and sealed in containers capable of protecting the contents from damage, with palletization following DLA requirement RP001. Non-hazardous materials must comply with ASTM D3951, while hazardous materials per FED-STD-313 must follow TQ requirement IP025. The item is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with the Buy American and Balance of Payments Program.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BUPIVACAINE AND EPINEP

Solicitation # SPE2DP-27-T-0139

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Sulfamethoxazole and Trimethoprim Tablet ProductionThis subcontract involves the production of USP-grade Sulfamethoxazole and Trimethoprim tablets in 400 mg/80 mg dosages for prime contractors supporting Department of Defense medical supply contracts. The selected manufacturer is responsible for formulating active pharmaceutical ingredients into tablets that adhere to strict USP specifications for potency and purity, ensuring a minimum shelf life of 36 months. Finished products must be delivered in bulk bottles containing 500 tablets each. To qualify, the provider must operate an FDA-registered pharmaceutical manufacturing facility and maintain full compliance with current Good Manufacturing Practices. The project is managed under the Medical Supply Chain Pharm FSA and is associated with performance in Fort Bragg. Interested parties should note the response deadline of October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Veterinary Ropinirole Ophthalmic Solution SupplyThis subcontract, managed by the Department of Defense Medical Supply Chain Pharm FSA, involves the supply of Veterinary Ropinirole Ophthalmic Solution for prime contractors on DLA medical supply contracts. The requirement is for a 30MG/ML clear solution packaged in 0.3 ML single-use droppers, with five units per box. The contract specifies the delivery of four boxes of the solution, which must maintain a shelf life of 24 months. To qualify, the provider must utilize FDA-regulated pharmaceutical manufacturing facilities and ensure full compliance with Medical Marking Standard No. 1. The performance of this contract is located in APO 09227-0000, with a response deadline set for October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of MIL-SPEC Electrical Insulation TapeThis subcontract involves the supply of 50,000 rolls of electrical insulation tape to support prime contractors for the Department of Defense under the DLA Weapons Support Maritime Supply Chain. The contractor is responsible for manufacturing or sourcing the tape in strict accordance with MIL-I-19166 and QPL/QML standards. Additionally, all products must adhere to MIL-STD-129 for marking and MIL-STD-2073-1E and RP001 for packaging requirements. To be eligible, the supplier must hold QPL or QML certification for MIL-I-19166 and maintain full compliance with Buy American regulations. The final delivery of the 50,000 rolls is designated for the Pearl Harbor Naval Shipyard IMF in Hawaii. This procurement falls under NAICS code 325412 and is managed by the DLA Weapons Support Maritime Supply Chain ESOC Buys.

DLA WEAPONS SUPPORT MARITIME SUPPLY CHAIN ESOC BUYS

POSTED

2 days ago

DEADLINE

in 1 day

AI Contract Overview

The contract awarded by the CDC Office of Acquisition Services pertains to the procurement of pediatric vaccines under the FY25 Vaccines for Children program. This initiative supports the purchase of standard commercial pediatric vaccines to ensure broad immunization coverage among children aged 18 and under, particularly targeting those who are Medicaid-eligible, uninsured, American Indian/Alaska Native, or insured but with coverage gaps for vaccines. The program is designed to promote cost-effective immunization practices by leveraging federal funds, including VFC and Section 317 vaccine purchase funds, enabling providers to acquire vaccines at prices below the commercial market rate. Healthcare providers meeting specific requirements can receive free vaccines through this contract, which also allows for the purchase of additional vaccine quantities using state and local funds to immunize children outside the federally vaccine-eligible population. Manufacturers eligible to participate must be recognized as vaccine producers under 42 U.S.C. § 1396s, encompassing any organization involved in manufacturing, importing, processing, or distributing pediatric vaccines. The contract emphasizes the importance of ensuring sufficient vaccine supply to support immunization efforts nationwide, with a response deadline of January 30, 2025. The solicitation, identified as number 75D30125R00065, is posted for potential vendors to submit proposals, with key contacts including James Sprigler and David Dombeck. The contract aims to facilitate the procurement of vaccines at competitive prices, ultimately supporting public health objectives by increasing immunization rates among vulnerable pediatric populations.

General Info

CDC solicits manufacturers for FY25 Vaccines for Children program to supply pediatric vaccines.

Agency

Department Of Health And Human Services → CDC Office Of Acquisition Services

Contract Value

$1,123,734,611.8

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Atlanta, GA, 30341, USA

Set-Aside

NONE

Awardee

PFIZER INC

Award Issued Date

04/01/2025, 12:00:00 AM UTC

Documents

Vaccine Order Limitation Chart

specifications

High

Authorized Distributor of Record (ADR) Agreement

contract-document

Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

2 updates

PhaseClosed

PostedJan 16

Combined Synopsis

Notice updatedJan 17

Notice details unchanged. Attachments may have changed.

Notice updatedJan 17

Notice details unchanged. Attachments may have changed.

Response DeadlineJan 30

Deadline has passed

Submission Closed

01/30/2025, 06:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → CDC Office Of Acquisition Services

Contacts2 people available

OfficeATLANTA, GA, 30333, USA

Organization / AgencyDepartment Of Health And Human Services → CDC Office Of Acquisition Services

Office AddressATLANTA, GA, 30333, USA

Contacts

James Sprigler

David Dombeck

Full Description

The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA - 93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are (1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA - 93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program. The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds. Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. - 1396s. The term "manufacturer" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or distribute a vaccine.